Luisa Sanchez-Lorenzo

Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 18, 2024

SENECA study: staging endometrial cancer based on molecular classification.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 17, 2024

SEOM-GEICO Clinical Guidelines on cervical cancer (2023).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 10, 2024

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 01, 2024

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 13, 2024

Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer.

Journal: Seminars in oncology nursing

Published: September 29, 2023

Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 01, 2022

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

Journal: Journal of personalized medicine

Published: September 26, 2022

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

Journal: Cancers

Published: February 22, 2022

Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study.

Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study.

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

SENECA study: staging endometrial cancer based on molecular classification.

SENECA study: staging endometrial cancer based on molecular classification.

SEOM-GEICO Clinical Guidelines on cervical cancer (2023).

SEOM-GEICO Clinical Guidelines on cervical cancer (2023).

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).

Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer.

Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer.

Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

Response of folliculotropic mycosis fungoides to capecitabine.

Response of folliculotropic mycosis fungoides to capecitabine.

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin.

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin.

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.